Risk for persistent sedative-hypnotic use among patients receiving adjuvant chemotherapyOctober 24, 2022Breast Cancer
Risk for second primary colorectal, pancreatic, and thyroid cancers elevated in male BC survivorsOctober 24, 2022Breast Cancer
pT1a-b ER+ BC: Endocrine therapy benefits patients with grade 2-3 tumorsOctober 24, 2022Breast Cancer
Re-BCS may not be the best strategy in ipsilateral breast tumor recurrenceOctober 24, 2022Breast Cancer
Differential prognosis of germline BRCA1/2 mutations according to tumor subtypesOctober 24, 2022Breast Cancer
HER2+ metastatic BC: Dual blockade with P + T effective and safe in routine clinical practiceOctober 24, 2022Breast Cancer
Metastatic TNBC: Apatinib + vinorelbine shows acceptable efficacy and safety in phase 2October 24, 2022Breast Cancer
Switching to fulvestrant + palbociclib benefits ER + HER2− BC patients with rising bESR1mutOctober 24, 2022Breast Cancer
Cost paramount when choosing metastatic breast cancer treatmentSeptember 30, 2022Metastatic Breast CancerBreast Cancer
